☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Structure Therapeutics
Structure Therapeutics Reports the First Patient Dosing in P-IIb (ACCESS) Trial of GSBR-1290 for Obesity
November 14, 2024
Load more...
Back to Home
Modal title
×
Modal body text goes here.